STAMBP and type 2 diabetes mellitus: A final group of five biomarkers (CXCL9, IL-2RB, MMP-10, STAMBP, TNF-α) showed positive associations with changes in CES-D in people with type 2 diabetes but without significant effect modification (pinteraction ≤ 0.18).